logo-loader
CVE:PDP

Pediapharm

Receive alerts
Market:
CVE
Market Cap:
£0.00
Price
£0.00
Change
0%
52 weeks high
0
52 weeks low
0

In brief

Pediapharm is the first and only specialty pharmaceutical corporation in Canada that exclusively distributes and licenses, innovative medicines used to treat pathological conditions that mainly affect children from infancy to eighteen (18) years of age.

Through its network’s ownership of the key stakeholders within the pediatric arena, Pediapharm’s key objective is to partner with leading healthcare entities around the world to bring innovative pediatric products to the Canadian market.

By doing so, the company contribute to help improve children’s health and quality of life of Canadian children; its partners can thus be assured of long-term commitment and unwavering integrity.

Pediapharm’s unique business model, company’s values and human capital, set it apart as Canada’s leading pediatric specialty pharmaceutical company.